Diabetes is associated with high risk of severe adverse events during chemotherapy for cancer patients: A single‐center study

Diabetes mellitus (DM) is a common comorbidity among cancer patients, but its impact on chemotherapy tolerance has not been widely studied. We aimed to compare the occurrence of severe grade 3/4 adverse events (G3/4 AEs) within 90 days of starting chemotherapy between patients with and without diabe...

Descripción completa

Detalles Bibliográficos
Autores principales: Mailliez, Aurélie, Ternynck, Camille, Duhamel, Alain, Mailliez, Audrey, Ploquin, Anne, Desauw, Christophe, Lemaitre, Madleen, Bertrand, Nicolas, Vambergue, Anne, Turpin, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Cancer Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087807/
https://www.ncbi.nlm.nih.gov/pubmed/36054752
http://dx.doi.org/10.1002/ijc.34268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087807/
https://www.ncbi.nlm.nih.gov/pubmed/36054752
http://dx.doi.org/10.1002/ijc.34268

Ejemplares similares